Experience of interruption of pregnancy by mifepriston's one tablet (200mg) in the combination with mizoprostol in out- patient practice of female consultation №22 of St.Petersburg
In article experience of female consultation №22 of St.Peters- burg on use of the modern scheme of medicamentous interrup- tion of pregnancy in early terms (till 63days of amenorea) in out- patient conditions is presented. In research results (efficiency and complications) pregnancy interruptions at 11542women of repro- ductive age by whom abortion by a method of a vacuum aspira- tion and a medicamentous method with use of 600mg and 200mg of mifepristone was executed are studied. It is shown that number of complications after medicamentous abortion (0,9%) in 2011 was less in comparison with vacuum экс- кохлеацией (1,5%) the same year. Dose reduction of mifepristone from 600mg to 200mg doesn't influence efficiency of medica- mentous abortion and number of complications, and improvement of quality of its performance conducts to reduction of complica- tions (with 2,2% in 2007 to 0,9% in 2011respectively). Carrying out an assessment of efficiency of medicamentous abortion in con- trol terms (for the 14thdays) is possible with definition use beta-HGCh a quantitative method instead of routine ultrasonography